Medtronic Plc. · NYSE:MDT

Medtronic — Technical Presentation (2017)

13 slides from Medtronic's technical presentation, 2017

  1. Slide 1: 2017 ACC/AHA/HRS Syncope Guidelines

    2017 ACC/AHA/HRS SYNCOPE GUIDELINES

  2. Slide 2: 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

    2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society Developed in Collaboration With the American College of Emergency P

  3. Slide 3: Evidence Level Definitions – New Descriptors

    EVIDENCE LEVEL DEFINITIONS – NEW DESCRIPTORS Note: types of clinical data qualify level of evidence •i.e. “randomized”/ ”non randomized” Source: Shen WK, et al. J Am Coll Cardiol. 2017. DOI: 10.1016/j.jacc.2017.03.003. 3

  4. Slide 4: Syncope Initial Evaluation

    SYNCOPE INITIAL EVALUATION Source: Shen WK, et al. J Am Coll Cardiol. 2017. DOI: 10.1016/j.jacc.2017.03.003. 4

  5. Slide 5: Characteristics Identifying Patients Most Likely to Be Associated With a Cardiac Cause

    CHARACTERISTICS IDENTIYING PATIENTS MOST LIKELY TO BE ASSOCIATED WITH A CARDIAC CAUSE Class LOE Recommendation Evaluation of the cause and assessment for the short- and long-term I B-NR morbidity and mortality risk of Syncope are recommended Historical Characteristics Associated with Increased Proba

  6. Slide 6: Characterizing Risk Score of Syncopal Patients

    CHARACTERIZING RISK SCORE OF SYNCOPAL PATIENTS Class LOE Recommendation Evaluation of the cause and assessment for the short- and long-term I B-NR morbidity and mortality risk of syncope are recommended Short-term (<30 d) risk factors Long-term (>30d) risk factors § Older age (>60yr) § Older age (>6

  7. Slide 7: Syncope Evaluation Care Pathway

    SYNCOPE EVALUATION CARE PATHWAY *Applies to patients after a normal initial evaluation without significant injury or cardiovascular morbidities; patients followed up by primary care physician as needed. † In selected patients. § After initial evaluation and if cardiac cause is suspected, cardiac mon

  8. Slide 8: Cardiac Monitoring Recommendations

    CARDIAC MONITORING RECOMMENDATIONS Class LOE Recommendation The choice of a specific cardiac monitor should be determined on the I C-EO basis of the frequency and nature of syncope events. To evaluate selected ambulatory patients with syncope of suspected IIa B-R arrhythmic etiology, an ICM can be u

  9. Slide 9: Monitoring Selection Criteria: The Right Device for the Right Patient

    MONITORING SELECTION CRITERIA THE RIGHT DEVICE FOR THE RIGHT PATIENT Holter Extended External Loop Mobile Cardiac Insertable Monitors Holters Recorders Telemetry Cardiac Monitors Duration 24 – 48 hrs 2-14 days Up to 1 month ≤3 years Patient Daily, Weekly Monthly Monthly, Recurrent, Selection symptom

  10. Slide 10: Class I and Class IIa Recommendations and Medtronic Portfolio

    Class I Cardiac Class IIa recommendation for recommendation for cardiac monitoring in Monitor both external and patients suspected of Selection insertable cardiac cardiac cause for monitors syncope Patient selection Based on specific Randomized clinical strategies and risk criteria: evidence support

  11. Slide 11: Clear Definitions for Syncope-Related Terms

    CLEAR DEFINITIONS FOR SYNCOPE-RELATED TERMS Term Definition/Comments Syncope A symptom that presents with an abrupt, transient, complete loss of consciousness, associated with inability to maintain postural tone, with rapid and spontaneous recovery. The presumed mechanism is cerebral hypoperfusion.

  12. Slide 12: Brief Statement

    BRIEF STATEMENT MEDTRONIC REVEAL LINQ™ LNQ11 INSERTABLE CARDIAC MONITOR AND PATIENT ASSISTANT Indications Warnings/Precautions REVEAL LINQ™ LNQ11 Insertable Cardiac Monitor REVEAL LINQ™ LNQ11 Insertable Cardiac Monitor The Reveal LINQ insertable cardiac monitor is an implantable Patients with the Re

  13. Slide 13: Brief Statement, cont'd

    BRIEF STATEMENT, cont’d MEDTRONIC MYCARELINK™ PATIENT MONITOR, MEDTRONIC CARELINK™ NETWORK AND CARELINK™ MOBILE APPLICATION The Medtronic MyCareLink Patient Monitor and the Medtronic CareLink Network are indicated for use in the transfer of patient data from Medtronic implantable cardiac devices. Th

Medtronic — Technical Presentation (2017) on 6ix